Human Phototoxicity Test
NCT02750475 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35
Last updated 2018-12-13
Summary
To determine the phototoxic potential of a topically applied article in human subjects
Conditions
- Sunscreening Agents
Interventions
- DRUG
-
Sunscreen Sport Lotion (BAY987516)
50 μl/cm\*2 or 0.05 gm/cm\*2 of each test product is applied to duplicate skin sites (approximately 2 x 2 cm each). After the test articles have dried for 5 to 15 min, the sites are covered by the appropriate patch.24 hours later, the set of patches covering the product are removed. Three (3) μl/ cm2 or 0.003 gm/cm\*2 of the test product is reapplied to the test site, air dried for 5 to 15 minutes for volatilization and then the test site is exposed to UVA radiation.(Formulation number - RB# Y65-110)
- OTHER
-
Untreated Skin
This site is patched without treatment as irradiated control
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Bayer Study Director · Bayer
Study Design
- Allocation
- NA
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-05-02
- Primary Completion
- 2016-05-06
- Completion
- 2016-05-06
Countries
- United States
Study Locations
More Related Trials
-
Outdoor-Use Test for Sunscreen Products in Children Ages 3 to 9 Years Old
NCT02831478 ·Status: COMPLETED ·Phase: NA
-
Pharmacokinetic (PK) Evaluation of Bemotrizinol (6%) in a Sunscreen Maximum Usage Trial
NCT05277376 ·Status: COMPLETED ·Phase: PHASE3
-
A Study in Healthy Men to Measure the Amount of BI 730357 in the Blood When Taken as a Tablet
NCT03804671 ·Status: COMPLETED ·Phase: PHASE1
-
Phototoxicity of Frequently Prescribed Medicines
NCT06710600 ·Status: COMPLETED ·Phase: NA
-
Single Dose of 7.5mg Tolvaptan Phase I Clinical Trial Protocol
NCT07166783 ·Status: COMPLETED ·Phase: PHASE1
-
Study of NST-6179 in Healthy Subjects
NCT05181085 ·Status: COMPLETED ·Phase: PHASE1
-
Dermal Phototoxicity Study
NCT04070742 ·Status: COMPLETED ·Phase: PHASE1
-
Study of the Pharmacokinetics of Intravenous Administered 14C-MNTX
NCT01367483 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics, Pharmacodynamics Profile and Tolerance of P03277 in Healthy Subjects and Patients With Brain Lesions
NCT03603106 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study in Healthy Men to Test How BI 730357 is Processed by the Body
NCT03664011 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of BP101 in Healthy Volunteers
NCT03102489 ·Status: COMPLETED ·Phase: PHASE1
-
This Study Tests BI 1467335 in Healthy Male Volunteers. The Study Tests How Different Doses of BI 1467335 Are Taken up and Handled by the Body
NCT03382509 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Men to Test How BI 1291583 is Processed in the Body
NCT05833035 ·Status: COMPLETED ·Phase: PHASE1
-
Ascending Dose Pharmacokinetic (PK) and Absolute Bioavailability (BA)
NCT00983255 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Look at How a Single Oral Dose of Carbon-14-Labelled [14C] BIIB091 Moves Through and is Processed by the Body in Healthy Male Participants
NCT06311786 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Absorption, Metabolism and Excretion Following a Single Oral Dose of [14C]KWA-0711 to Healthy Male Subjects
NCT02434835 ·Status: COMPLETED ·Phase: PHASE1
-
Single Dose and Multiple Dose Trial to Assess Pharmacokinetics of Obeticholic Acid (OCA)
NCT01933503 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics, Safety, and Tolerability of Methylnaltrexone in Volunteers With Impaired Hepatic Function
NCT01367522 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Dabigatran Etexilate in Patients With Moderate Hepatic Impairment Compared to Subjects With Normal Hepatic Function
NCT02170571 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Calderasib (MK-1084) Human Absorption, Distribution, Metabolism, and Excretion in Healthy Adult Participants (MK-1084-006)
NCT06687759 ·Status: COMPLETED ·Phase: PHASE1
-
A PK and Safety Study in Subjects With Hepatic Impairment
NCT01431833 ·Status: COMPLETED ·Phase: PHASE1
-
Study on the Safety of BAY 63-2521, How it is Tolerated and the Way the Body Absorbs, Distributes and Gets Rid of the Study Drug Given as a Single Oral Dose of 1 mg Tablet in Participants With Renal Impairment and Healthy Participants Matched for Age-, Gender-, and Weight
NCT04364464 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Safety and Pharmacokinetics of HBI-002, an Oral Carbon Monoxide Therapeutic, in Healthy Volunteers
NCT03926819 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Effect of Multiple-Dose Ritlecitinib on the Pharmacokinetics (PK) of Tolbutamide
NCT05097716 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of ABT-436 in Healthy Adults
NCT01050127 ·Status: COMPLETED ·Phase: PHASE1